TrialJournal of translational medicine2012
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
Thomas F Gajewski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled ittrialcites it